{
  "author": {
    "name": "Angus Worthing",
    "webUrl": "/author/profile/angus-worthing/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 1,
    "social": [],
    "articles": [
      {
        "uri": "/2019/03/29/will-pbms-be-held-to-account-for-their-role-in-drug-price-hikes/",
        "title": "Will PBMs be held to account for their role in drug price hikes?",
        "byline": "Angus Worthing",
        "kicker": "Commentary",
        "prettyDate": "March 29, 2019",
        "timeToRead": "4 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2019/03/2019-3-16-senate-aging-drug-cost-hearing_SenateSpecialCommitteeonAging_MI.jpg",
          "width": "616",
          "height": "372"
        },
        "authors": [
          {
            "webUrl": "/author/profile/angus-worthing/",
            "name": "Angus Worthing"
          }
        ],
        "kickerNode": [
          {
            "uri": "/commentary/",
            "sectionName": "Commentary"
          }
        ],
        "summary": "PBMs have rightfully come under increasing scrutiny, and their practices have attracted the notice of the Senate Finance Committee. ",
        "body": null
      }
    ]
  }
}